Search

Integra is a biotechnology company that is creating next-generation gene writing tools to boost the efficiency and safety of advanced therapies

The acquisition strengthens Agomab as a leader in targeting growth factor pathways Origo Biopharma is a Spanish biotech founded in Galicia by Julio Castro and GalChimia, and led by Ramon Bosser Asabys

The food industry is no stranger to changes and adapts in order to maintain its competitiveness and quality, both locally and internationally

Agreement strengthens Bayer’s new cell and gene therapy platform further / Supports Mammoth’s vision of unlocking the full potential of novel CRISPR systems / Mammoth to receive upfront payment of USD

AseBio regrets the fact that Spanish manufacturers of SARS-CoV-2 antigen detection tests have not been at any point considered as an essential component of the solution to the pandemic

This amendment aims to extend the scope and timelines for the transition to the new regulation and thus avoid the disruption in the supply of IVDs on the European market.

The association has more than 284 members, 65.5% of which focus on biotechnology for healthcare, nearly 17% on biotech for agrifood and 16.5% on industrial biotech

Analyze, manage, aggregate, and explore data at scale with Illumina Connected Analytics, a comprehensive, secure, cloud-based data platform empowering genomics researchers.

Learn why research leaders decided to use Multiomics in their work.

Serbian arm final deployment in PORTICO. Study already active in Spain, Bulgaria, Germany and USA

40º Annual J.P. Morgan Healthcare Conference Biotech Showcase 2022 11º Annual LifeSci Partners Corporate Access Event 2022 H.C. Wainwright Bioconnect Conference BioMed Event 2022 in París

Two chemists, when they had barely turned 25, set up a spin-off of the University of the Balearic Islands that has just been acquired by Vifor Pharma in the biggest biotechnology operation in Spain

The Instituto Aragonés de Ciencias de la Salud (IACS) and the Instituto de Investigación Sanitaria de Aragón (IIS Aragón) have organised this conference on 24, 25 and 26 November in collaboration with

Robust efficacy - ORR 78%, of which 62% are CR/CRi 77% of CR/CRi lasting more than 6 months Longest remission beyond 1,000 days, still ongoing Iadademstat and azacitidine combination shows a good

Machine Learning, Network Analysis and Modularity are some of the key features of the company’s latest pipeline. Under the framework of SME Phase2 project, UNLOCK-EDD, funded by EC Horizon 2020

The investment will be used to develop an innovative gene editing platform with the potential to make advanced therapies safer and more effective